Frederic Krohn
Direktor/Vorstandsmitglied bei DAS Therapeutics, Inc.
Ursprung des Netzwerks ersten Grades von Frederic Krohn
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
DAS Therapeutics, Inc.
 DAS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology DAS Therapeutics, Inc. is a clinical stage pharmaceutical company. It acquires and develops assets for conditions overlooked or under-served by current treatment approaches to improve patient outcomes. The company was founded by Raimonds Dzelme, Christina Cognata-Smith and Michael Nemmers in 2016 and is headquartered in Boston, MA.
4
| Private Company | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Frederic Krohn
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| GT BIOPHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
TargetRx, Inc.
 TargetRx, Inc. Miscellaneous Commercial ServicesCommercial Services TargetRx, Inc. provides pharmaceutical and biotech enterprises with insight into the drivers of prescribing. The firm offers various solutions, which include forecasting, positioning, and promotional decisions for new drug launches; optimizing marketing messages and materials for campaign development; and measurement and optimization of execution for sales and marketing execution. TargetRx was founded by Michael J. Luby and Sangam Pant in 1999 and is headquartered in Horsham, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Pharmaceuticals: Major | Founder | |
| COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Thunderbird School of Global Management | College/University | Masters Business Admin | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
| Pacific University | College/University | Undergraduate Degree | |
| Université François-Rabelais de Tours | College/University | Doctorate Degree | |
American Academy of Neurology
 American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services American Academy of Neurology operates a professional society which represents neurologists and neuroscientists. The company was founded in 1948 and is headquartered in Minneapolis, MN. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Lundbeck, Inc.
 Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin. | Pharmaceuticals: Major | Sales & Marketing | |
| Km Pharmaceutical Consulting LLC | Founder | ||
| Prestwick Scientific Capital, Inc. | Founder | ||
| Prestwick Chemical, Inc. | Founder | ||
| Saatchi & Saatchi Healthcare SA | Corporate Officer/Principal | ||
OXIS Biotech, Inc.
 OXIS Biotech, Inc. BiotechnologyHealth Technology OXIS Biotech, Inc. develops innovative drugs for the treatment of cancer. It also focuses on developing drugs for the treatment of other unmet medical needs. The company was founded by Kathleen E. Clarence-Smith on September 26, 2014 and is headquartered in Tampa, FL. | Biotechnology | Founder | |
Georgetown Translational Pharmaceuticals, Inc.
 Georgetown Translational Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Georgetown Translational Pharmaceuticals, Inc. provides treatment for neuropathic pain, refractory epilepsies, the symptoms of myasthenia gravis, and motion sickness. The company was founded by Kathleen Clarence-Smith and Mark J. Silverman and is headquartered in United States. | Hospital/Nursing Management | Founder | |
Chase Therapeutics Corp.
 Chase Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chase Therapeutics Corp. operates as healthcare company. The company was founded in 2017 and is headquartered in Washington, DC. | Pharmaceuticals: Major | Chairman | |
| Riverside Pharmaceuticals Corp. | Miscellaneous | Director/Board Member | |
| Westhaven Therapeutics Corp. | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 22 |
| Frankreich | 4 |
| Italien | 2 |
Sektoral
| Health Technology | 11 |
| Commercial Services | 5 |
| Consumer Services | 4 |
| Finance | 2 |
| Health Services | 2 |
Operativ
| Corporate Officer/Principal | 12 |
| Founder | 10 |
| Director/Board Member | 6 |
| Chairman | 2 |
| Chief Executive Officer | 2 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Frederic Krohn
- Unternehmensverbindungen
